Literature DB >> 23780667

Posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus after cessation of oral prednisone.

Qi Li1, Fajin Lv, Youdong Wei, Bernard Yan, Peng Xie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23780667     DOI： 10.1007/s10072-013-1479-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  Posterior reversible encephalopathy syndrome in systemic lupus erythematosus.

Authors:  Irlapati Rajendra Varaprasad; Sumeet Agrawal; Vadivelmurugan Nagasubramani Naga Prabu; Liza Rajasekhar; Meena Angamuthu Kanikannan; Gumdal Narsimulu
Journal:  J Rheumatol       Date:  2011-05-15       Impact factor: 4.666

3.  Is hypertension predictive of clinical recurrence in posterior reversible encephalopathy syndrome?

Authors:  Richard Li; Peter Mitchell; Richard Dowling; Bernard Yan
Journal:  J Clin Neurosci       Date:  2012-12-07       Impact factor: 1.961

4.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

5.  Posterior reversible encephalopathy syndrome as a complication of acute lupus activity.

Authors:  José Fidel Baizabal-Carvallo; Héctor Manuel Barragán-Campos; Héctor Javier Padilla-Aranda; Marlene Alonso-Juarez; Bruno Estañol; Carlos Cantú-Brito; Guillermo García-Ramos
Journal:  Clin Neurol Neurosurg       Date:  2009-01-06       Impact factor: 1.876
  5 in total
  1 in total

1.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.